Anti-Integrin beta 7 antibody [EPR1357] (ab108926)


  • Product nameAnti-Integrin beta 7 antibody [EPR1357]
    See all Integrin beta 7 primary antibodies
  • Description
    Rabbit monoclonal [EPR1357] to Integrin beta 7
  • Tested applicationsSuitable for: WB, ICCmore details
    Unsuitable for: Flow Cyt,IHC-P or IP
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide corresponding to residues in Human Integrin beta 7.

  • Positive control
    • Human peripheral blood mononuclear cell lysate, Human tonsil lystate, and THP-1 cell lysate
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

    A trial size is available to purchase for this antibody.

    Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.



Our Abpromise guarantee covers the use of ab108926 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 87 kDa.
ICC 1/100 - 1/250.
  • Application notesIs unsuitable for Flow Cyt,IHC-P or IP.
  • Target

    • FunctionIntegrin alpha-4/beta-7 (Peyer patches-specific homing receptor LPAM-1) is an adhesion molecule that mediates lymphocyte migration and homing to gut-associated lymphoid tissue (GALT). Integrin alpha-4/beta-7 interacts with the cell surface adhesion molecules MADCAM1 which is normally expressed by the vascular endothelium of the gastrointestinal tract. Interacts also with VCAM1 and fibronectin, an extracellular matrix component. It recognizes one or more domains within the alternatively spliced CS-1 region of fibronectin. Interactions involves the tripeptide L-D-T in MADCAM1, and L-D-V in fibronectin. Binds to HIV-1 gp120, thereby allowing the virus to enter GALT, which is thought to be the major trigger of AIDS disease. Interaction would involve a tripeptide L-D-I in HIV-1 gp120. Integrin alpha-E/beta-7 (HML-1) is a receptor for E-cadherin.
    • Tissue specificityExpressed in a variety of leukocyte lines.
    • Sequence similaritiesBelongs to the integrin beta chain family.
      Contains 1 VWFA domain.
    • DomainDomain I contains three cation-binding sites: the ligand-integrin-binding site (LIMBS), the metal ion-dependent adhesion site (MIDAS), and the adjacent to MIDAS site (ADMIDAS). In the absence of a ligand or in calcium-dependent binding, only ADMIDAS is occupied. In magnesium-dependent binding all three sites bind metal ions. LIMBS positively modify ligand binding whereas ADMIDAS negatively modify ligand binding.
    • Cellular localizationMembrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • Gut homing receptor beta subunit antibody
      • Integrin beta 7 subunit antibody
      • Integrin beta-7 antibody
      • Integrin beta-P antibody
      • Integrin, beta 7 antibody
      • ITB7 antibody
      • ITB7_HUMAN antibody
      • Itgb7 antibody
      • Ly69 antibody
      • M290 IEL antigen antibody
      see all

    Anti-Integrin beta 7 antibody [EPR1357] images

    • All lanes : Anti-Integrin beta 7 antibody [EPR1357] (ab108926) at 1/1000 dilution

      Lane 1 : Human peripheral blood mononuclear lysate
      Lane 2 : Human tonsil lysate
      Lane 3 : THP-1 cell lysate

      Lysates/proteins at 10 µg per lane.

      Predicted band size : 87 kDa

    References for Anti-Integrin beta 7 antibody [EPR1357] (ab108926)

    ab108926 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab108926.
    Please use the links above to contact us or submit feedback about this product.